Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism

NCT06140095 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT06140095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06140095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism
Lead sponsor
Region Stockholm
Phase
Phase 1
Overall status
Unknown status
Start date
February 29, 2024
Completion date
December 31, 2025
Enrollment
8 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute metabolic effects of evolocumab and atorvastatin